Clinical trial / 2017
Pomegranate extract reduced disease activity and some inflammatory markers in rheumatoid arthritis.
In this randomized trial of 55 patients with rheumatoid arthritis, daily intake of 500 mg pomegranate extract for 8 weeks significantly lowered Disease Activity Score 28 (P<0.001), tender and swollen joints, pain intensity, and erythrocyte sedimentation rate compared to placebo. Supplementation also decreased Health Assessment Questionnaire scores (P=0.007) and raised glutathione peroxidase concentrations (P<0.001). However, changes in matrix metalloproteinases 3, C-reactive protein, and malondialdehyde did not differ between groups.
- Study type
- Randomized controlled trial
- Who was studied
- 55 adults with rheumatoid arthritis
- What was measured
- Disease activity, joint counts, pain, and inflammatory and oxidative biomarkers
THE PAPER
Pomegranate extract alleviates disease activity and some blood biomarkers of inflammation and oxidative stress in Rheumatoid Arthritis patients.
Ghavipour M, Sotoudeh G, Tavakoli E, Mowla K, Hasanzadeh J, Mazloom Z. Eur J Clin Nutr, 2017.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.